Heart palpitations, brain fog, and that bone-deep exhaustion that no amount of sleep seems to fix — these were the things that sent me down the taurine rabbit hole in the first place. Nobody was talking about it in the menopause conversation, which felt strange once I started reading the research. It's not a magic fix, but understanding why your body may be running lower on it after 40 felt like one more useful piece of a complicated puzzle.
Learn more about Rose →Taurine is a conditionally essential amino sulfonic acid found in high concentrations in the heart, brain, skeletal muscle, and retina. A landmark 2023 study published in Science found that taurine levels in blood decline by approximately 80% between youth and older age across multiple species, including humans. This age-related depletion positions taurine as a molecule of genuine interest for anyone studying the biology of aging — which now includes menopause researchers.
Animal and early human studies suggest estrogen plays a role in regulating the enzymes involved in taurine biosynthesis and transport. When estrogen drops during perimenopause and menopause, the body's ability to produce and utilize taurine efficiently may be compromised beyond what normal aging alone would predict. This creates a biologically plausible reason why menopause-specific research into taurine supplementation is now beginning to gain traction.
Mitochondria require taurine to properly synthesize certain transfer RNA molecules used in the production of key proteins in the electron transport chain — the cellular machinery that generates ATP, the body's primary energy currency. When taurine is deficient, mitochondrial efficiency drops, contributing to the kind of persistent, unrelenting fatigue that many women report in perimenopause and menopause. Research in animal models has consistently shown that taurine supplementation restores mitochondrial respiratory chain function in depleted cells.
Multiple meta-analyses have found associations between taurine intake and lower blood pressure, reduced arterial stiffness, and improved endothelial function — all of which become pressing concerns after estrogen loss removes its cardioprotective effects. Taurine appears to modulate calcium signaling in heart muscle cells, reduce oxidative stress in arterial walls, and support healthy blood pressure through its interaction with the renin-angiotensin system. Given that cardiovascular disease risk climbs sharply in the decade after menopause, these mechanisms are directly relevant.
Chronic low-grade inflammation — sometimes called inflammaging — increases after menopause as estrogen's anti-inflammatory signaling is withdrawn. Taurine is a precursor to taurine chloramine, a compound that suppresses the production of pro-inflammatory cytokines including TNF-alpha and interleukin-6, both of which are elevated in postmenopausal women. Reducing this inflammatory burden is increasingly understood as central to managing symptoms ranging from joint pain to cardiovascular risk in the menopause transition.
Taurine acts as a neuromodulator in the brain, binding to GABA receptors — the same inhibitory pathways that estrogen influences and that are disrupted when estrogen declines, contributing to anxiety, poor sleep, and cognitive changes. Animal studies have shown taurine supplementation increases GABA activity, reduces neuroinflammation, and supports hippocampal neurogenesis, the process by which the brain generates new neurons in memory-related regions. Human clinical data in this specific area is limited but accumulating.
Insulin sensitivity declines during the menopause transition, increasing the risk of weight gain, type 2 diabetes, and metabolic syndrome. Several small randomized controlled trials have found that taurine supplementation improves insulin sensitivity and reduces fasting blood glucose in adults with metabolic risk factors. The proposed mechanism involves taurine's ability to reduce oxidative stress in pancreatic beta cells and improve glucose transporter function in muscle tissue.
A high-profile study published in Science in June 2023 by Singh et al. found that taurine supplementation extended healthy lifespan in mice and worms, and was associated with improved muscle function, bone density, immune health, and reduced fat accumulation in middle-aged mice — a profile that maps closely onto what happens to the female body during menopause. While the leap from mouse data to human clinical outcomes requires caution, the study's scope and the quality of the journal have prompted researchers to design human trials specifically around aging and taurine, some of which are now underway.
Taurine occurs naturally in meat, seafood, and dairy, and is one of the most studied ingredients in the food and supplement industry with a well-documented safety profile at doses up to 3 grams per day in adults. However, the optimal dose, timing, and formulation for menopausal women specifically has not yet been established through dedicated clinical trials, and women on medications for heart conditions, blood pressure, or diabetes should discuss any supplementation with their prescribing clinician given taurine's activity in those systems. The emerging evidence is promising enough to watch closely — but not yet definitive enough to treat taurine as a replacement for any established menopause treatment.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.